|Prof. Lawrence Steinman BA, M.D.||Exec. Chairman & Co-Founder||72.92k||N/A||1948|
|Dr. Tiago Reis Marques||CEO & Director||243.75k||N/A||1978|
|Mr. Stanley M. Gloss||Chief Financial Officer||67.5k||N/A||1960|
|Dr. Yassine Bendiabdallah Ph.D.||COO, Head of UK Clinics & Director||N/A||N/A||1986|
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.